| Chemically modified oligonucleotides with improved delivery properties |
2022-12-29 |
2023-7-06 |
|
| Immunotherapy of cancer |
2022-12-22 |
2023-5-16 |
|
| Immunotherapy of cancer utilizing natural killer cells treated with chemically … |
2022-8-04 |
2023-2-09 |
|
| Chemically modified oligonucleotides |
2022-8-04 |
2023-2-09 |
|
| Reduced size self-delivering nucleic acid compounds targeting long non-coding … |
2022-1-04 |
2022-4-19 |
|
| Rna interference in dermal and fibrotic indications |
2021-3-23 |
2021-7-29 |
|
| REDUCED SIZED SELF-DELIVERING RNAi COMPOUND |
2021-3-04 |
2021-7-15 |
|
| Methods for treating aging and skin disorders using nucleic acids targeting tyr … |
2021-1-15 |
2021-11-11 |
|
| Chemically modified oligonucleotides with improved systemic delivery |
2020-12-31 |
2023-3-23 |
|
| Chemically modified oligonucleotides targeting bromodomain-containing protein 4 … |
2020-11-06 |
2022-9-30 |
|
| Rna interference in ocular indications |
2020-5-12 |
2021-3-04 |
|
| Methods for treatment of alopecia areata utilizing gene modulation approaches |
2020-4-07 |
2020-7-30 |
|
| RNA duplexes with single stranded phosphorothioate nucleotide regions for … |
2019-11-11 |
2023-6-06 |
2023-6-06 |
| Methods for treatment of wound healing utilizing chemically modified … |
2019-9-30 |
2020-3-05 |
|
| Effective sensitizing dose of a gelled immunomodulating topical composition |
2019-4-08 |
2020-4-02 |
|
| Reduced size self-delivering RNAI compounds |
2019-2-07 |
2021-9-14 |
2021-9-14 |
| Inhibition of pcsk9 through rnai |
2018-11-14 |
2019-7-18 |
|
| Modified rnai polynucleotides and uses thereof |
2018-10-05 |
2019-6-06 |
|
| Chemically modified oligonucleotides |
2018-8-07 |
2020-3-05 |
|
| Topical delivery of nucleic acid compounds |
2018-4-19 |
2020-3-19 |
|
| Methods for treating skin disorders and conditions utilizing haptens |
2016-9-09 |
2019-3-27 |
|
| Bioactive conjugates for oligonucleotide delivery |
2016-8-12 |
2017-2-16 |
|
| Nucleic acid molecules targeting superoxide dismutase 1 (SOD1) |
2016-7-06 |
2021-5-11 |
2021-5-11 |
| Methods for treating neurological disorders using a synergistic small molecule … |
2016-7-06 |
2018-7-12 |
|
| Fully stabilized asymmetric sirna |
2016-4-01 |
2016-11-03 |
|
| Oligonucleotide compounds for targeting huntingtin mRNA |
2016-4-01 |
2017-11-07 |
2017-11-07 |
| Oligonucleotide compounds for treatment of preeclampsia and other angiogenic … |
2016-4-01 |
2018-1-09 |
2018-1-09 |
| Inhibition of map4k4 through rnai |
2015-6-02 |
2016-4-28 |
|
| Methods for treatment of disorders in the front of the eye utilizing nucleic … |
2015-5-01 |
2015-11-05 |
|
| Methods for treating cancer using nucleic acids targeting MDM2 or MYCN |
2015-4-28 |
2022-3-22 |
2022-3-22 |
| Means and methods for the specific modulation of target genes in the cns and … |
2014-12-19 |
2015-4-16 |
|
| Compositions and methods for sirna inhibition of angiogenesis |
2013-9-30 |
2014-2-27 |
|
| Compositions and methods for inhibition of vegf |
2012-7-23 |
2013-2-14 |
|
| RNA interference in ocular applications |
2011-3-24 |
2016-8-31 |
2016-8-31 |
| Sirna and methods of manufacture |
2010-12-15 |
2011-6-16 |
|
| Compositions and methods for selective inhibition of VEGF |
2009-12-04 |
2013-6-25 |
2013-6-25 |
| Rnai constructs and uses therof |
2009-7-23 |
2010-1-28 |
|
| Phagocytic cell delivery of rnai |
2009-7-17 |
2012-1-19 |
|
| Tripartite rnai constructs |
2008-10-02 |
2010-7-14 |
|
| COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
2007-6-12 |
2008-6-26 |
|
| Novel compositions of chemically modified small interfering rna |
2007-1-23 |
2010-3-18 |
|
| Compositions and methods for regulating complement system |
2006-12-22 |
2007-8-02 |
|
| Gelled immunomodulating topical compositions and a method of treating warts and … |
2005-9-16 |
2006-9-21 |
|
| 眼への適用におけるｒｎａ干渉 |
2011-3-24 |
2016-8-31 |
2016-8-31 |